Cardiovascular Systems Rides on New Products Amid Tight Race

By -
On May 21, we issued an updated research report on Cardiovascular Systems, Inc. CSII . Notably, a number of factors continue to drive optimism for the stock. For instance, the company's firm position in the coronary arterial disease (CAD) and peripheral arterial disease (PAD) market spaces, positive study results highlighting its effective technologies, an impressive portfolio expansion as well as a strong gross margin scenario. The player carries a Zacks Rank #3 (Hold).
This medical device manufacturer, developer and marketer of innovative solutions, which  treat patients with peripheral and coronary arterial diseases including those with arterial calcium, saw a solid third quarter of fiscal 2018. The company witnessed a year-over-year rise in revenues at both CAD and PAD businesses. Also, the gross margin expansion was impressive. 
Over the past three months, shares of Cardiovascular Systems have outperformed its industry . The stock has surged 32.2% compared with the 5.1% increase of the industry.


Comments

Post a Comment

Popular posts from this blog

Global Neurovascular Devices Market Growth Opportunities 2018 – , Medtronic, and Stryker Corporation

By -
Image
The research report on “Global Neurovascular Devices Market” reveals exclusive information regarding the leading players of neurovascular devices market, product launches, market segments, technological development,  neurovascular devices  industry chain structure and policies by region, along with five-year forecasts to assess how the market is anticipated to grow. neurovascular devices report delivers complete details about revenue generation by differing profiles of top leaders of neurovascular devices market. It also displays a comprehensive study of global neurovascular devices market competitive landscape, market drivers, challenges, and constraints, operator case studies, key developments and neurovascular devices market tendencies, future guidelines, methods and worth chain. Thereafter neurovascular devices report gives a precise summary of various growth opportunities, inventive business strategies, neurovascular devices product scope, market size, growth estimations,
Read more

Heart risk calculator due for an update

By -
Image
Over 11 million Americans are at high risk of having a heart attack or  stroke  in the next 10 years — at least, that’s what the numbers say. The equation doctors use to estimate  cardiovascular  risk is prone to miscalculation, according to a new study, meaning patients may be popping daily aspirin or statins at the wrong dosage. The stakes are higher for African-Americans. With the old equation, 1 in 29 African-Americans may be incorrectly labeled very low or very high risk, according to the study. For example, a 46-year-old black man was estimated to have a 40 percent lower chance of having a heart attack or stroke than a white man of the same age and in identical health. In general, African-Americans are at higher risk of cardiovascular conditions than Caucasians, so miscalculations shouldn’t be taken lightly. The heart risk calculator transforms patient information — age, gender, race,  cholesterol  levels, blood pressure, prescriptions, and whether they are diabetic or a
Read more

Vascular Graft Market Expected to Increase at a CAGR 5.0% through 2016 to 2024

By -
Image
Vascular graft has been a prosthetic of choice among the vascular and other cardiovascular surgeons worldwide due to its strong, inert and biocompatible design which also varies in sizes and configurations in order to improve vascular access. The rise in vascular graft usage has been increased due to increase in cardiovascular diseases and diabetes. Increase in geriatric population, demand of new technological advancements in vascular access, rise in demand of vascular grafts among vascular patients can also accelerate the growth in  vascular graft market . Risk of infection due to diabetes mellitus and immune response can increase some serious complications such as sepsis, amputation, disruption of infected anastomotic rigid line with a rupture, etc. can restrain the market growth. The global vascular graft market is forecast to reach US$3.29 bn by the end of 2024, from US$2.15 bn in 2015. If these figures hold true, the global vascular grafts market will exhibit a CAGR of 5.0% be
Read more